ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-20194

A vulnerability in the web-based management interface of Cisco IOS XE Software could allow an authenticated, low-privileged, remote attacker to perform an injection attack against

Published May 7, 2025 · catalog updated Feb 26, 2026 · Cisco Cisco IOS XE Software

Check this week

CVE-2025-20194 is not in CISA KEV. FIRST estimates a 33.00% chance of exploitation in the next 30 days. Check whether you run Cisco Cisco IOS XE Software.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.4
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
33.00%
Remediation
Advisory link
Affected products
vendor Cisco Cisco IOS XE Software 17.14.1

A vulnerability in the web-based management interface of Cisco IOS XE Software could allow an authenticated, low-privileged, remote attacker to perform an injection attack against an affected device. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by sending crafted input to the web-based management interface. A successful exploit could allow the attacker to read limited files from the underlying operating system or clear the syslog and licensing logs on the affected device.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Cisco Cisco IOS XE Software 17.14.117.14.1

How to fix CVE-2025-20194

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-20194 is not in CISA KEV. FIRST estimates a 33.00% chance of exploitation in the next 30 days. Check whether you run Cisco Cisco IOS XE Software.

Which versions are affected?

Compare what you have installed with Cisco Cisco IOS XE Software 17.14.1 17.14.1. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 33.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Cisco security

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 7, 2025 · EUVD

    Detected

    A vulnerability in the web-based management interface of Cisco IOS XE Software could allow an authenticated, low-privileged, remote attacker to perform an injection attack against an affected device. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by sending crafted input to the web-based management interface. A successful exploit could allo

  2. Feb 26, 2026 · EUVD

    Updated

    A vulnerability in the web-based management interface of Cisco IOS XE Software could allow an authenticated, low-privileged, remote attacker to perform an injection attack against an affected device. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by sending crafted input to the web-based management interface. A successful exploit could allo

Sources

  • CVE.orgVulnerability recordCVE-2025-20194

    Official CVE identifier

    cve.org
  • EUVDVulnerability recordEUVD-2025-13888

    A vulnerability in the web-based management interface of Cisco IOS XE Software could allow an authenticated, low-privileged, remote attacker to perform an injection attack against an affected device. This vulnerability is due to insufficient input validation. An attacker could ex

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 17, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.